BrainRepair
Phase 1Who we are? German Start-up, EMA SME Qualification EMA/SME/357/15/R1. To develop autologous (own) cord blood stem cell therapies in Europe/USA for the treatment of Pediatric brain injury. Our product was granted ATMP-TEP Classification by EMA
Founded
2018
Focus
Cell & Gene Therapy
About
Who we are? German Start-up, EMA SME Qualification EMA/SME/357/15/R1. To develop autologous (own) cord blood stem cell therapies in Europe/USA for the treatment of Pediatric brain injury. Our product was granted ATMP-TEP Classification by EMA
Funding History
2Total raised: $4.7M
Seed$3.5MHigh-Tech GründerfondsMay 15, 2021
Grant$1.2MGerman Federal Ministry of Education and ResearchOct 15, 2019
Company Info
TypePrivate
Founded2018
LocationMunich, Germany
StagePhase 1
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile